Kraig Biocraft Laboratories, Inc. (KBLB): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2013-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Older than the company's other figures. The latest EBITDA is for the year ended 2018-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

-$933.3K
Year ended 2018-12-31
2011-12-31: -$1.29M2012-12-31: -$1.55M2013-12-31: -$2.21M2014-12-31: -$1.83M2015-12-31: -$2.04M2016-12-31: -$2.93M2017-12-31: -$2.14M2018-12-31: -$933.3K-$933.3K
2011-12-31 EBITDA (USD) 2018-12-31
Period endedEBITDAChange YoYSource filing
2018-12-31-$933.3Kn/m2020-03-27, From 2018-01-01
2017-12-31-$2.14Mn/m2019-03-29, From 2017-01-01
2016-12-31-$2.93Mn/m2018-03-23, From 2016-01-01
2015-12-31-$2.04Mn/m2017-03-22, From 2015-01-01
2014-12-31-$1.83Mn/m2016-03-30, From 2014-01-01
2013-12-31-$2.21Mn/c2015-03-31, From 2013-01-01
2012-12-31-$1.55Mn/m2014-04-15, From 2012-01-01
2011-12-31-$1.29Mn/a2013-12-24, From 2011-01-01